A quarter century ago, Barry Karger and his team published research in the journal Proceedings of the National Academy of Sciences that would help enable scientists to sequence the human genome.
Lyme is one of those puzzling chronic diseases: while people that are treated by antibiotics shortly after they’re bitten by the tic get cured, about 10 to 20 percent don’t. Why not?
ScanDrop is a portable instrument no bigger than a shoebox that has the capacity to detect a variety of biological specimen.
Dr. John Engen utilizes hydrogen exchange mass spectrometry to make confirmation of biosimilars a feasible task. His work was recently highlighted in the journal Biopharm International.
Alan Guttmacher, director of NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development, on the impact new tools and technologies have had on use-inspired research.
Recent work from University Distinguished Professor of Biology Kim Lewis promises to overcome MRSA, one of the leading public health threats of our time.
Dr. Pollastri said the secrecy model of protecting research and data doesn’t work when it comes to curing infectious diseases.
Associate Professor of Biology Jacqueline Piret, her former student Desislava Raytcheva, and colleagues at MIT and Baylor College of Medicine publish research on analyzing ancient bacteria in the journal Nature.
Biotechnology startup Quad Technologies makes it to the final round of the prestigious 2013 MassChallenge.
Panelists at career development event offer tips on job searching, networking, and interviewing to students preparing for co-op work experience.